MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming
Open Access
- 1 April 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Abstract
Recent data have shown that liver fibrosis can regress even at later stages of cirrhosis and shifting the immune response from pro-inflammatory towards a resolutive profile is considered as a promising option. The immune regulatory networks that govern the shift of the inflammatory phenotype and thus potential reversal of liver fibrosis are lesser known. Here we show that in precision-cut human liver slices obtained from patients with end-stage fibrosis and in mouse models, inhibiting Mucosal-Associated Invariant T (MAIT) cells using pharmacological or antibody-driven approaches, limits fibrosis progression and even regresses fibrosis, following chronic toxic- or non-alcoholic steatohepatitis (NASH)-induced liver injury. Mechanistic studies, combining RNA sequencing, in vivo functional studies (performed in male mice) and co-culture experiments indicate that disruption of the MAIT cell-monocyte/macrophage interaction results in resolution of fibrosis both by increasing the frequency of restorative Ly6Clo at the expenses of pro-fibrogenic Ly6Chi monocyte-derived macrophages and promoting an autophagic phenotype in both subsets. Thus, our data show that MAIT cell activation and the consequential phenotype shift of liver macrophages are important pathogenic features of liver fibrosis and could be targeted by anti-fibrogenic therapy.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR19-CE14-0041-02)
- Fondation pour la Recherche Médicale (FRM EQU202203014642)
This publication has 44 references indexed in Scilit:
- Cellular Mechanisms of Tissue Fibrosis. 5. Novel insights into liver fibrosisAmerican Journal of Physiology-Cell Physiology, 2013
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyThe Lancet, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosisProceedings of the National Academy of Sciences, 2012
- MR1 presents microbial vitamin B metabolites to MAIT cellsNature, 2012
- Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signalingProceedings of the National Academy of Sciences, 2012
- Antimicrobial activity of mucosal-associated invariant T cellsNature Immunology, 2010
- CCR2 promotes hepatic fibrosis in mice #Hepatology, 2009
- Dual Role of CCR2 in the Constitution and the Resolution of Liver Fibrosis in MiceThe American Journal of Pathology, 2009
- Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1Nature, 2003